Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China

Background To determine the efficacy of low-dose, immediate-release tacrolimus in patients with myasthenia gravis (MG) with inadequate response to glucocorticoid therapy in a randomized, double-blind, placebo-controlled study. Methods Eligible patients had inadequate response to glucocorticoids (GCs...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Lei Zhou, Weibin Liu, Wei Li, Haifeng Li, Xu Zhang, Huifang Shang, Bitao Bu, Hui Deng, Qi Fang, Jimei Li, Hua Zhang, Zhi Song, Changyi Ou, Chuanzhu Yan, Tao Liu, Hongyu Zhou, Jianhong Bao, Jiahong Lu, Huawei Shi, Chongbo Zhao
التنسيق: Artigo
اللغة:Inglês
منشور في: SAGE Publishing 2017-09-01
سلاسل:Therapeutic Advances in Neurological Disorders
الوصول للمادة أونلاين:https://doi.org/10.1177/1756285617721092
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة